ArticleNeurochemical research2025
Mechanisms of Intermittent Theta-Burst Stimulation Upregulates TFEB and Restores Autophagy to Play a Neuroprotective Role in the Acute Phase After Cerebral Ischemia Reperfusion.
Article in Neurochemical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Repetitive transcranial magnetism (rTMS) exerts neuroprotective function in the cerebral ischemia/reperfusion (I/R) injury during the early stage. Intermittent theta-burst stimulation (iTBS), a more time-efficient modality of rTMS, improves the efficiency without at least decreasing the efficacy of the therapy. However, little is known about the neuroprotective mechanisms of iTBS. We aimed to investigate the potential regulatory mechanisms by which iTBS attenuates the early stages of nerve injury after I/R in rats. In in vitro experiments, a therapeutic regimen of iTBS was administered to primary cortical neuronal cells. The Cell Counting Kit-8 (CCK-8) assay was then used for determination of cell viability. The expression of autophagy, ferroptosis-related markers was detected by protein immunoblotting. Mitochondrial membrane potential was examined using JC-1, and mitochondrial reactive oxygen species (ROS) production was measured using MitoSOX staining to assess mitochondrial ROS production. In in vivo experiments, rats were stimulated with iTBS or 10 Hz rTMS. Expression of autophagy and ferroptosis-related markers were detected by protein immunoblotting, and the effects of transcranial magnetic stimulation on oxidative stress in rat serum were further investigated. We also measured the motor function of rats by behavioral tests, in addition to observing neuronal cells in the cortex of rats by Nissl staining and HE staining. In this way, we investigated the mechanism of iTBS to attenuate the nerve injury after I/R in rats. The results of in vitro experiments showed that iTBS reduced neuronal cell injury after OGD, increased mitochondrial autophagy, thereby reducing mitochondrial ROS generation, restored the decrease in mitochondrial membrane potential, and attenuated ferroptosis. In in vivo experiments, we compared the effects of two common treatment modalities, iTBS and 10 Hz rTMS, and investigated the mechanism by which magnetic stimulation exerts a protective effect on neuronal cells, demonstrating that it was able to alleviate the nerve damage of I/R by upregulating the TFEB level, and improved the motor coordination and balance ability of rats. In addition, the results showed that the therapeutic effect of iTBS was not inferior to that of 10 Hz rTMS model. In the present study, we compared the effects of these two common therapeutic modalities in in vivo experiments and investigated the mechanism by which magnetic stimulation exerts a protective effect on neurons. In addition, iTBS can reduce the cost per treatment by several times without compromising the therapeutic efficacy, and can be a practical and less costly intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.